|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 470.72 USD | -1.34% |
|
-1.73% | +3.83% |
| Aug. 03 | Vertex Pharmaceuticals Incorporated, Q2 2026 Earnings Call, Aug 03, 2026 | |
| Aug. 03 | Vertex Pharmaceuticals Bumps Up Fiscal Year Outlook on Growth of Cystic Fibrosis Drugs | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Other Pharmaceuticals | -1.34% | -1.73% | +3.83% | +1.86% | +135.30% | 119B |  |  |  |
- Stock Market
- Stocks
- VRTX Stock
- Charts Vertex Pharmaceuticals Incorporated
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
